Hong Kong
· Delayed Price · Currency is HKD Sino Biopharmaceutical Statistics
Total Valuation
HKG:1177 has a market cap or net worth of HKD 94.79 billion. The enterprise value is 100.86 billion.
| Market Cap | 94.79B |
| Enterprise Value | 100.86B |
Important Dates
The next estimated earnings date is Monday, August 25, 2025.
| Earnings Date | Aug 25, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
HKG:1177 has 17.88 billion shares outstanding. The number of shares has decreased by -2.36% in one year.
| Current Share Class | 17.88B |
| Shares Outstanding | 17.88B |
| Shares Change (YoY) | -2.36% |
| Shares Change (QoQ) | -1.25% |
| Owned by Insiders (%) | 50.58% |
| Owned by Institutions (%) | 18.14% |
| Float | 8.84B |
Valuation Ratios
The trailing PE ratio is 47.48 and the forward PE ratio is 27.35. HKG:1177's PEG ratio is 1.77.
| PE Ratio | 47.48 |
| Forward PE | 27.35 |
| PS Ratio | 3.09 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.89 |
| P/FCF Ratio | 15.75 |
| P/OCF Ratio | 13.47 |
| PEG Ratio | 1.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.82, with an EV/FCF ratio of 16.76.
| EV / Earnings | 27.08 |
| EV / Sales | 3.28 |
| EV / EBITDA | 13.82 |
| EV / EBIT | 16.68 |
| EV / FCF | 16.76 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.26 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | 1.72 |
| Interest Coverage | 19.66 |
Financial Efficiency
Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 7.02%.
| Return on Equity (ROE) | 11.82% |
| Return on Assets (ROA) | 5.62% |
| Return on Invested Capital (ROIC) | 7.02% |
| Return on Capital Employed (ROCE) | 12.65% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | 152,772 |
| Employee Count | 24,379 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.44 |
Taxes
In the past 12 months, HKG:1177 has paid 524.55 million in taxes.
| Income Tax | 524.55M |
| Effective Tax Rate | 9.34% |
Stock Price Statistics
The stock price has increased by +92.03% in the last 52 weeks. The beta is 0.71, so HKG:1177's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +92.03% |
| 50-Day Moving Average | 4.37 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 64.30 |
| Average Volume (20 Days) | 188,393,821 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1177 had revenue of HKD 30.72 billion and earned 3.72 billion in profits. Earnings per share was 0.20.
| Revenue | 30.72B |
| Gross Profit | 25.04B |
| Operating Income | 6.17B |
| Pretax Income | 5.62B |
| Net Income | 3.72B |
| EBITDA | 7.34B |
| EBIT | 6.17B |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 15.77 billion in cash and 10.33 billion in debt, giving a net cash position of 5.44 billion or 0.30 per share.
| Cash & Cash Equivalents | 15.77B |
| Total Debt | 10.33B |
| Net Cash | 5.44B |
| Net Cash Per Share | 0.30 |
| Equity (Book Value) | 45.52B |
| Book Value Per Share | 1.90 |
| Working Capital | 5.46B |
Cash Flow
In the last 12 months, operating cash flow was 7.04 billion and capital expenditures -1.02 billion, giving a free cash flow of 6.02 billion.
| Operating Cash Flow | 7.04B |
| Capital Expenditures | -1.02B |
| Free Cash Flow | 6.02B |
| FCF Per Share | 0.34 |
Margins
Gross margin is 81.51%, with operating and profit margins of 20.10% and 12.12%.
| Gross Margin | 81.51% |
| Operating Margin | 20.10% |
| Pretax Margin | 18.28% |
| Profit Margin | 12.12% |
| EBITDA Margin | 23.88% |
| EBIT Margin | 20.10% |
| FCF Margin | 19.59% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 1.51%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 1.51% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 19.65% |
| Buyback Yield | 2.36% |
| Shareholder Yield | 3.91% |
| Earnings Yield | 3.93% |
| FCF Yield | 6.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
HKG:1177 has an Altman Z-Score of 2.75 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 6 |